Thus, our analysis may be generalized to patients receiving GLP-1 RAs without a diagnosis of diabetes or obesity, thus further confirming the complementary nature of studies based on ICSRs disproportionality analysis and longitudinal observational design. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.